Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Revised US industry code bans entertainment and gifts

This article was originally published in RAJ Devices

Executive Summary

US medtech industry association AdvaMed says it has made major revisions to its code of ethics on interactions with healthcare professionals that further “clarify and distinguish between” appropriate and inappropriate activity between healthcare professionals and representatives of AdvaMed member companies1. The revised code, which takes effect on 1 July 2009, explicitly prohibits companies from providing entertainment or recreation to healthcare professionals and prohibits gifts of any type, including all non-educational branded promotional items, regardless of value.

You may also be interested in...



EU Decision Thwarts Novartis's Near-Term Piqray Ambitions

Novartis seems to have accepted the fact that the indication granted for Piqray in the EU means there is little scope for the advanced breast cancer drug to be used in markets such as the UK.

EU Accelerated Assessment Tracker

Sanofi failed in its attempt to have its EU marketing authorization application for avalglucosidase alfa fast-tracked through the centralized review process at the European Medicines Agency. This and other developments relating to the agency's accelerated assessment mechanism are logged in this latest update to the Pink Sheet's EU accelerated assessment tracker.

Preparing To Lead EMA, Cooke Routes Road Ahead For Pharma Regulation At Agency Conference

Change in leadership at the European Medicines Agency comes at a critical time.

UsernamePublicRestriction

Register

MT142578

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel